|

Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization

RECRUITINGSponsored by University Hospital, Basel, Switzerland
Actively Recruiting
SponsorUniversity Hospital, Basel, Switzerland
Started2021-07-01
Est. completion2029-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04595630

Summary

This study is to evaluate the correlation between hs-cTn level as cardiac biomarker for ischemia and early graft occlusion as assessed by CCT in patients undergoing coronary bypass surgery.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* patients with isolated coronary bypass surgery

Exclusion Criteria:

* Patients withholding or lacking informed consent
* Patients requiring a concomitant procedure
* Exclusion criteria concerning the CCT scan
* Patients with known allergy to iodine-containing contrast agents
* Renal function impairment (serum creatinine \>140 mmol/l; estimated glomerular filtration rate (GFR) \<30 ml/min/1.73 m2).
* Pregnancy
* Unstable clinical state or severe heart failure
* Patients with registered MI and registered bypass occlusion in coronary angiogram
* Patients that didn't undergo a CCT prior to discharge

Conditions2

Coronary Bypass Graft OcclusionHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.